Latest Royalties News

Kore Potash has signed non-binding term sheets for a $2.2 billion financing package to develop its Kola Potash Project, marking a significant step toward construction. The company also progressed environmental assessments and strengthened government relations during Q2 2025.

Ragnar Metals reported a cash outflow for the June quarter, leaving just over one quarter of funding available, yet it remains optimistic about upcoming royalty income and future financing.

Rapid Critical Metals has completed a $10.5 million capital raise to acquire major silver projects in New South Wales, appointed Byron Miles as Managing Director, and expanded its land holdings near the Webbs Silver Project by 26 times.

Australian Oil Company Limited reported stable gas production from key wells and completed a $1 million loan forgiveness settlement, while refocusing its portfolio away from less promising leases.

High Peak Royalties Limited reported stable royalty receipts of A$345,240 for the June 2025 quarter, maintaining cash flow while advancing monitoring of key gas and geothermal assets across Australia and the US.

Hawthorn Resources is progressing its Anglo Saxon gold project with an approved drilling program and advancing mining lease applications at Mt Bevan, while maintaining a strong cash position.

DGR Global Limited reports steady progress in project generation and subsidiary investments, bolstered by a $23.5 million loan facility and a favorable legal appeal outcome. The company maintains a strong health, safety, and environmental record while navigating challenging market conditions.

Sabre Resources reports promising uranium and rare earth element discoveries at its Dingo Project while securing $1.6 million from the sale of its Ninghan Gold Project, strengthening its financial position for ongoing exploration.

Rumble Resources has boosted its Western Queen gold resource by 29% to 370,000 ounces at a higher grade, while advancing underground mining studies and preparing a maiden tungsten resource estimate. Simultaneously, the company progresses its Earaheedy zinc-lead-silver scoping study, signaling a pivotal phase for its Western Australian portfolio.

Cambium Bio has cleared key regulatory hurdles for its lead dry eye disease treatment, Elate Ocular, and strengthened its balance sheet with a $2.12 million placement to support upcoming Phase 3 trials.

Emmerson Resources’ latest scoping study confirms the White Devil gold deposit as a major mine with a robust resource base and strong financial metrics, setting the stage for feasibility studies and production growth.

Tombador Iron Limited reported a solid cash position of AUD 9.549 million as it advances the acquisition of the Colomi Iron Project in Brazil, while navigating royalty income challenges and preparing for a capital raise.